Document is current
Any future updates will be listed below
-
Authors
Sacilotto, Nathália de Carvalho https://orcid.org/0000-0003-3984-9282
Giorgi, Rina Dalva Neubarth
Vargas-Santos, Ana Beatriz
de Albuquerque, Cleandro Pires
Radominski, Sebastião Cezar
Pereira, Ivânio Alves
Guimarães, Maria Fernanda Brandão Resende
Bértolo, Manoel Barros
Louzada, Paulo Jr
Sauma, Maria de Fátima Lobato da Cunha
Bonfiglioli, Karina Rossi
Brenol, Claiton Viegas
da Mota, Licia Maria Henrique
Castelar-Pinheiro, Geraldo da Rocha
- License Information
-
More Information
Article History
Received: 13 October 2018
Accepted: 17 February 2020
First Online: 14 March 2020
Ethics approval and consent to participate
: This study was approved by the National Commission of Ethics in Research (CONEP-Comissão Nacional de Ética em Pesquisa) – Ministry of Health and by the Institutional Review Board of each of the centers involved. All patients signed the informed consent form.
: Not aplicable.
: Nathália de Carvalho Sacilotto: Janssen; - RinaDalva Neubarth Giorgi: UCB, Lilly, Pfizer, Janssen, Roche; - Ana Beatriz Vargas-Santos: None; - Cleandro Albuquerque: Pfizer, Abbvie, AstraZeneca, Janssen, Bristol-Myers-Squibb, Roche, Novartis and UCB; - Sebastião Radominski: None; - Manoel Barros Bertolo: Roche, Abbvie, Pfizer; - Ivânio Pereira: None; - Paulo Louzada-Junior: Bristol-Myers Squibb, UCB, Pfizer; - Maria de Fátima Cunha Sauma: None; - Karina Bonfiglioli, Roche, Janssen, Pfizer,Abbvie; - Claiton Brenol:Abbvie, BMS, Janssen, Pfizer and Roche; Maria Fernanda ResendeGuimarães: None; Licia Maria Henrique Mota: Abbvie, Janssen, Pfizer, Roche and UCB; - Geraldo Castelar-Pinheiro: Abbvie, Bristol-Myers Squibb, Eli Lilly, Glaxo Smith Kline, Janssen, Pfizer, Sanofi Genzyme and Roche.
